FDA.reportPublic FDA data

benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon]

RxCUI
1431687
RxNorm name
benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon]
Term type
SBD
Status
Active
Updated
2026-08-08 11:37:45

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082013
Active start
082013
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzalkonium chloride0.0013 MG / 1 MGbenzalkoniumbenzalkonium chloride
lidocaine hydrochloride0.02 MG / 1 MGlidocainelidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Gel346286

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzalkonium1378
lidocaine6387

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRCicloferon (benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % ) Topical Gel1NAMES
RxNorm Namebenzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon]1NAMES
RxNorm SynonymCicloferon (benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % ) Topical Gel1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID89081ef8-9721-a476-e053-2995a90ae0de1CODES
RxCUI14316871CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
59208-002-0459208-002CICLOFERON benzalkonium chloride and lidocaine hydrochlorideLaboratorios Liomont, S.A. de C.V.M003
59208-002-0559208-002CICLOFERON benzalkonium chloride and lidocaine hydrochlorideLaboratorios Liomont, S.A. de C.V.M003

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M00359208-002CICLOFERON benzalkonium chloride and lidocaine hydrochlorideOTC MONOGRAPH DRUGLaboratorios Liomont, S.A. de C.V.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11SourceActive
59208000204rxnav_ndcsyes
59208000205rxnav_ndcsyes
75940012202rxnav_historical
75940012204rxnav_historical
75940012205rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CICLOFERONBENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDELaboratorios Liomont, S.A. de C.V.89081ef8-9721-a476-e053-2995a90ae0de2024-10-17WarningsExact identifier
ndc (package): 59208-002-04
ndc (package): 59208-002-05
ndc (product): 59208-002
ndc11 (package): 59208000204
ndc11 (package): 59208000205
rxcui: 1431687

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e2c62b5f-56ee-4d04-9c19-26849fe2b2b1CICLOFERON 0.13 % / 2 % Topical Gel [PSN] · benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon] [SBD] · Cicloferon (benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % ) Topical Gel [SY]37Drug Facts20191219
89081ef8-9721-a476-e053-2995a90ae0deCICLOFERON 0.13 % / 2 % Topical Gel [PSN] · benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon] [SBD] · Cicloferon (benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % ) Topical Gel [SY]32CiclofrnGel20241017

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
89081ef8-9721-a476-e053-2995a90ae0deCiclofrnGelLaboratorios Liomont, S.A. de C.V.20241017
e2c62b5f-56ee-4d04-9c19-26849fe2b2b1Drug FactsMarcasUSA LLC | Laboratorios Liomont, S.A. de C.V.20191219

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCR02AAAntisepticsATC1-4benzalkonium
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCD09AAMedicated dressings with antiinfectivesATC1-4benzalkonium
ATCD08AJQuaternary ammonium compoundsATC1-4benzalkonium
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD001548Benzalkonium CompoundsCHEMhas_ingredientbenzalkonium
MEDRTD001548Benzalkonium CompoundsCHEMhas_ingredientbenzalkonium chloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD001424Bacterial InfectionsDISEASEmay_preventbenzalkonium
MEDRTD001424Bacterial InfectionsDISEASEmay_preventbenzalkonium chloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzalkonium chloride
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzalkonium
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.0013 MG/MG / 0.02 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable SynonymCICLOFERON 0.13 % / 2 % Topical Gel
SOURCESSourceMetathesaurus FDA Structured Product Labels